This guideline summarises the evidence on maternal and fetal outcomes in women with epilepsy (WWE). It provides recommendations on the care of WWE during the prepregnancy, antepartum, intrapartum and postpartum periods.
The guideline does not cover the methods of diagnosis of epilepsy, detailed categorisation of seizures or strategies for the management of epilepsy. These are addressed in detail in the National Institute for Health and Care Excellence clinical guideline and Scottish Intercollegiate Guidelines Network publication.
Declaration of interests (guideline developers)
Professor S Thangaratinam MRCOG, London: Professor Thangaratinam has received a study grant from Barts Charity. She is Project Coordinating Lead for the EMPiRE trial, which is funded by the National Institute for Health Research Health Technology Assessment programme. She is also an Executive Board member on the Maternal Medicine Clinical Study Group; the group is sponsored by MacDonald UK Obstetric Medicine Society and British Maternal and Fetal Medicine Society.
Dr F Fong MRCOG, London: None declared.
Dr D McCorry MD, FRCP, University Hospital Birmingham NHS Trust, Birmingham: Dr McCorry has received consulting fees or honoraria for advisory board meetings, and payment for lectures from both Eisai and UCB.
Mr AM Pirie FRCOG, Birmingham: Mr Pirie is National Obstetric Lead for the EMPiRE trial, which is funded by the National Institute for Health Research Health Technology Assessment programme. He has received payment for a commissioned textbook chapter, and fees for expert testimony.
Dr M Bagary PhD, MRCPsych, Birmingham: Dr Bagary has received consulting fees or honoraria for attending advisory boards, commercial support for attending conferences, and payment for lectures from both Eisai and UCB.
Mrs L Greenhill, Birmingham: None declared.